Navigation Links
New Device Offers Hope to People Blinded Due to Incurable Eye Disorders
Date:11/16/2013

NEW ORLEANS, Nov. 16, 2013 /PRNewswire-USNewswire/ -- Research presented today at the 117th Annual Meeting of the American Academy of Ophthalmology shows promising data about a device that helps people who have lost their vision due to a blinding genetic disease to recognize common objects. In the study, the researchers found when the objects' outlines had been enhanced, there was increased recognition. The device, called the Argus II, is the first FDA-approved retinal implant for adults with retinitis pigmentosa.

(Logo: http://photos.prnewswire.com/prnh/20130405/MM89329LOGO)

Retinitis pigmentosa is a group of genetic disorders that affect the retina's ability to respond to light. The disease, which is inherited and affects about 1 in 4,000 Americans, causes slow loss of vision, beginning with decreased night vision and loss of peripheral vision and eventually leads to blindness.[i] Up to one-quarter of all patients with retinitis pigmentosa will become legally blind in both eyes.[ii] There is currently no cure for retinitis pigmentosa.

The Argus II retinal prosthesis is a system in which a miniature video camera is housed in the subject's glasses and sends information to a patient-worn video processing unit where the image captured by the camera is processed into instructions which are then transmitted wirelessly to a retinal implant fitted with 60 electrodes. These electrodes pulse to stimulate cells in the retina, transmitting visual information along the optic nerve to the brain, creating the perception of patterns of light.

In the study, eight patients wearing the retinal prosthesis were asked to identify white or metallic objects against a dark background, then were asked to identify the same objects with enhanced outlines. The tests were done in three ways – with the retinal prosthesis turned on in a standard mode, in a scrambled mode as a positive control, and turned off as a negative control.

The results for solid object identification rose from 12.5 percent correct with the device switched off to 32.8 percent with the device on with 26.2 percent correct identification when the device was scrambled. Results for the outlined object identification were at 9.4 percent with the device turned off and 41.4 percent with the device on, with 20.7 percent correct identification in scrambled mode. 

"Despite the small sample size, statistically the results have achieved significance due to the magnitude of change in the performance of the use of the device within each subject." said Yvonne Luo, MA, FRCOphth, of London's Moorfields Eye Hospital NHS Foundation Trust and lead researcher on the study. "Moreover, these subjects represent people with the most severe form of the disease."

The Argus II is the only device currently on the market in the United States and is one of several devices intended to help people suffering from this disease. Other devices and therapies in development include an implanted microchip, electrical stimulation therapy, implantable capsules of timed-release medication, nutrient therapies to reduce retinal damage and gene therapies to halt or reverse retinitis pigmentosa. Another study on this device will be presented on Monday and will review the initial results of a 30 subject study, adverse events post-implant, system reliability and visual function results.

The study, The Use of the Argus II Retinal Prosthesis to Identify Common Objects in Blind Subjects With Outer Retinal Dystrophies (PO181) was presented today at the 117th Annual Meeting of the American Academy of Ophthalmology which is in session November 16-19 at Ernest N. Morial Convention Center in New Orleans. More than 25,000 attendees from 123 countries and 500 organizations gather each year to showcase the latest in ophthalmic education, research, clinical developments, technology, products and services. To learn more about the place Where All of Ophthalmology Meets, visit http://www.aao.org/2013.

About the American Academy of Ophthalmology
The American Academy of Ophthalmology, headquartered in San Francisco, is the world's largest association of eye physicians and surgeons — Eye M.D.s — with more than 32,000 members worldwide. Eye health care is provided by the three "O's" – ophthalmologists, optometrists, and opticians. It is the ophthalmologist, or Eye M.D., who has the education and training to treat it all: eye diseases, infections and injuries, and perform eye surgery. For more information, visit www.aao.org. The Academy's EyeSmart® program educates the public about the importance of eye health and empowers them to preserve healthy vision. EyeSmart provides the most trusted and medically accurate information about eye diseases, conditions and injuries. OjosSanos™ is the Spanish-language version of the program. Visit www.geteyesmart.org or www.ojossanos.org to learn more.

[i] http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm

[ii] http://ghr.nlm.nih.gov/condition/retinitis-pigmentosa


'/>"/>
SOURCE American Academy of Ophthalmology
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global IV Fluid Transfer Devices Products, Players, Markets and Opportunities Report 2013
2. Global Drug Injection Devices (Devices, Markets, Strategies and Forecasts) Market Report 2013 - 2018
3. Pre-Owned Medical Devices Market is Expected to Reach USD 4.9 Billion Globally in 2019: Transparency Market Research
4. Despite A Difficult Competitive Environment, Opportunities Can Still Be Found In The Growing US Trauma Fixation Device Market
5. Olympus Ranked Among Top 10 Innovators in Medical Devices and Services Industry
6. Current Regulatory Expectations Affecting the Validation of Reusable Medical Devices is Subject of Dec. 4th Seminar in Boston
7. Latin American Peripheral Vascular Device Market Will Expand Strongly To reach Revenues of $335 Million in 2022
8. FDA Advisory Panel Votes Favorably on the First of Its Kind Hybrid Hearing Device from Cochlear
9. Unilife Announces Supply Agreement with MedImmune for Wearable Injectable Drug Delivery Devices
10. Syneron Medical And Unilever Ventures Create Iluminage Beauty, A Global Joint Venture In Home Beauty Devices
11. Global Embolic Protection Devices (EPD) - Market Growth Analysis, 2009-2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... 27, 2016 Amarantus BioScience Holdings, Inc. ... products for Regenerative Medicine, Neurology and Orphan Diseases, today announced that ... at two upcoming investor conferences: SeeThru Equity MicroCap ... New York City , NY When: ... Marcum MicroCap Conference   Where: Grand Hyatt Hotel, 109 ...
(Date:5/26/2016)... TARE (Transarterial Radio-embolization) Using ... and Overall Decreased Use of Hospital Resource ... specialist healthcare company, has today announced the publication ... of ISPOR (International Society for Pharmacoeconomics and Outcomes ... using yttrium-90 glass microspheres is associated with cost ...
(Date:5/25/2016)... -- According to a new market research ... by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by Application (Drug ... Hospitals/ Clinics) - Forecast to 2021", published by MarketsandMarkets, ... the forecast period of 2016 to 2021. This market ... from USD 117.3 Million in 2016, at a CAGR ...
Breaking Medicine Technology:
(Date:5/27/2016)... Killeen, Texas (PRWEB) , ... May 27, 2016 , ... ... with satisfying Army body fat composition regulations. This is the first time that ... are normally screened at least every six months to ensure they meet the prescribed ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... scholarships to students studying complementary medicine. Allison Outerbridge is this year’s Life ... award on May 18 at the university’s Student Leadership Awards ceremony. , Outerbridge ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook ... Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of the ... is their favorite way to cook a hot dog, far outpacing other cooking methods ...
(Date:5/26/2016)... Missouri (PRWEB) , ... May 26, 2016 , ... ... quality and clinical outcomes, hosted members and suppliers for its inaugural Member Conference ... focus on their mission of elevating the operational health of America’s healthcare providers. ...
(Date:5/26/2016)... Washington, D.C. (PRWEB) , ... May 26, 2016 , ... ... the men and women who lost their lives in military battle for the country. ... discount cards in 2015 to provide more programs that empower independence for disabled military ...
Breaking Medicine News(10 mins):